Intraprocedural parenchymal blood volume as a marker of reperfusion status in acute ischemic stroke intervention

BMJ Case Rep. 2013 Aug 20:2013:bcr2013010756. doi: 10.1136/bcr-2013-010756.

Abstract

Parenchymal blood volume (PBV) mapping with flat panel detectors may provide real-time estimates of tissue perfusion during endovascular ischemic stroke procedures. We present two cases of acute middle cerebral artery (MCA) occlusion to demonstrate how PBV may: (1) be used in acute stroke; (2) influence intraprocedural decision-making; and (3) potentially serve as a predicator of clinical outcome. Both cases were successfully recanalized with endovascular embolectomy. Intraprocedural PBV maps were obtained immediately before and after recanalization. Pre-intervention reductions in PBV were seen throughout the MCA territory in both cases, with significant improvement in PBV in one case with good radiographic and clinical outcome and a lack of improvement in PBV in the second case with a large infarct volume. PBV deficit normalization may occur with recanalization of the parent artery and probably represents successful reperfusion. Baseline PBV maps should therefore be interpreted with caution and not interpreted to represent irreversible core infarct.

Keywords: Angiography; Artery; Embolic; Stroke.

Publication types

  • Case Reports

MeSH terms

  • Blood Volume
  • Blood Volume Determination / methods
  • Brain / blood supply*
  • Carotid Artery, Internal, Dissection / complications
  • Carotid Artery, Internal, Dissection / diagnostic imaging*
  • Carotid Artery, Internal, Dissection / therapy*
  • Cerebral Angiography / methods
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / diagnostic imaging*
  • Infarction, Middle Cerebral Artery / drug therapy
  • Male
  • Middle Aged
  • Perfusion Imaging / methods*
  • Stents
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator